Island Pharmaceuticals (ILA.AX) Earnings Analysis
Island Pharmaceuticals (ILA.AX) next reports earnings on 2026-08-27, consensus EPS -0.0124 AUD. Trailing P/E -13.68.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ILA.AX next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | -0.0124 AUD |
| Revenue estimate | n/a |
ILA.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-28 | -0.0122 AUD | n/a | n/a | n/a |
| 2025-06-30 | -0.01173 AUD | n/a | n/a | n/a |
| 2025-02-26 | -0.0107 AUD | n/a | n/a | n/a |
| 2024-12-31 | -0.0107 AUD | n/a | n/a | n/a |
ILA.AX valuation and analyst view
| Trailing P/E | -13.68 |
|---|---|
| Trailing EPS | -0.02843 AUD |
| Price / book | 14.86 |
| Dividend yield | 0.00% |
| Market cap | 0.10B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Island Pharmaceuticals (ILA.AX)'s next earnings date?
Island Pharmaceuticals is next scheduled to report on 2026-08-27, with a consensus EPS estimate of -0.0124 AUD.
Did ILA.AX beat earnings last quarter?
Consensus estimate data was not available for ILA.AX's 2025-08-28 report.
What is ILA.AX's current P/E ratio and EPS?
ILA.AX trades at a trailing P/E of -13.68 on trailing EPS of -0.028425164425929142 AUD.
What do analysts rate ILA.AX?
ILA.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.